Published in Diabetes Care on January 01, 2007
Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics (2009) 1.75
Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients. Diabetes Care (2008) 1.20
Early electrophysiological abnormalities and clinical neuropathy: a prospective study in patients with type 1 diabetes. Diabetes Care (2013) 0.96
The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes (2012) 0.94
Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep (2014) 0.93
Proinsulin C-peptide regulates ribosomal RNA expression. J Biol Chem (2009) 0.90
Intracellular signalling by C-peptide. Exp Diabetes Res (2008) 0.89
Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes. Exp Diabetes Res (2008) 0.89
C-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC study. Diabetes Care (2012) 0.88
Autonomic neuropathy in diabetes mellitus. Front Endocrinol (Lausanne) (2014) 0.87
The beneficial effects of C-Peptide on diabetic polyneuropathy. Rev Diabet Stud (2009) 0.84
C-peptide increases Na,K-ATPase expression via PKC- and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells. PLoS One (2011) 0.83
Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model. Proc Natl Acad Sci U S A (2012) 0.83
C-peptide: a new mediator of atherosclerosis in diabetes. Mediators Inflamm (2012) 0.82
Physiological effects and therapeutic potential of proinsulin C-peptide. Am J Physiol Endocrinol Metab (2014) 0.81
C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients. Exp Diabetes Res (2008) 0.79
C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia. Inflamm Res (2011) 0.79
C-Peptide and atherogenesis: C-Peptide as a mediator of lesion development in patients with type 2 diabetes mellitus? Exp Diabetes Res (2008) 0.79
Intrathecal administration of IGF-I by AAVrh10 improves sensory and motor deficits in a mouse model of diabetic neuropathy. Mol Ther Methods Clin Dev (2014) 0.77
C-Peptide in the vessel wall. Rev Diabet Stud (2009) 0.77
The clinical measures associated with C-peptide decline in patients with type 1 diabetes over 15 years. J Korean Med Sci (2013) 0.77
Anti-inflammatory properties of C-Peptide. Rev Diabet Stud (2009) 0.76
Association between serum C-peptide as a risk factor for cardiovascular disease and high-density lipoprotein cholesterol levels in nondiabetic individuals. PLoS One (2015) 0.76
The Association Between Fasting C-peptide and Gastrointestinal Symptoms of Gastroparesis in Type 2 Diabetic Patients. J Neurogastroenterol Motil (2016) 0.75
Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes. Am J Physiol Regul Integr Comp Physiol (2013) 0.75
C-Peptide and vascular complications in type 2 diabetic subjects. Diabetes Metab J (2012) 0.75
C-peptide is independent associated with diabetic peripheral neuropathy: a community-based study. Diabetol Metab Syndr (2017) 0.75
Implementing a Reference Measurement System for C-peptide: Successes and Lessons Learned. Clin Chem (2017) 0.75
Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care (2006) 6.25
Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care (2011) 3.30
The role of obstructive sleep apnea in metabolic syndrome: a population-based study in women. Sleep Med (2011) 2.66
Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44
PET and MRI show differences in cerebral asymmetry and functional connectivity between homo- and heterosexual subjects. Proc Natl Acad Sci U S A (2008) 2.28
Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med (2008) 2.13
Central and peripheral haemodynamic effects of hyperglycaemia, hyperinsulinaemia, hyperlipidaemia or a mixed meal. Clin Sci (Lond) (2003) 2.07
Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis (2009) 1.97
CPAP treatment of a population-based sample--what are the benefits and the treatment compliance? Sleep Med (2006) 1.97
Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes (2005) 1.96
Robustly estimating the flow direction of information in complex physical systems. Phys Rev Lett (2008) 1.94
Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J Biol Chem (2002) 1.85
Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscle. J Clin Endocrinol Metab (2003) 1.75
The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods. Diabetologia (2014) 1.72
The economic and quality of life impact of hypoglycemia. Eur J Health Econ (2005) 1.61
Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab (2006) 1.61
Brain response to putative pheromones in homosexual men. Proc Natl Acad Sci U S A (2005) 1.60
Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J Lipid Res (2005) 1.60
Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab (2010) 1.49
Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care (2005) 1.42
Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen. Clin Ther (2004) 1.36
AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm Res (2007) 1.35
Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes (2006) 1.33
Brain response to putative pheromones in lesbian women. Proc Natl Acad Sci U S A (2006) 1.33
C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes (2002) 1.32
The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Diabetes (2005) 1.32
Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. Am J Physiol Endocrinol Metab (2004) 1.29
The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care (2003) 1.25
Removal of Ca2+ channel beta3 subunit enhances Ca2+ oscillation frequency and insulin exocytosis. Cell (2004) 1.22
Transthyretin constitutes a functional component in pancreatic beta-cell stimulus-secretion coupling. Proc Natl Acad Sci U S A (2005) 1.22
Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care (2006) 1.21
Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid. J Lipid Res (2007) 1.20
Physical activity and quality of life in subjects with chronic disease: chronic obstructive pulmonary disease compared with rheumatoid arthritis and diabetes mellitus. Scand J Prim Health Care (2009) 1.17
Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study. Pediatr Diabetes (2008) 1.15
Associations between short sleep duration and central obesity in women. Sleep (2010) 1.15
Evaluation of a web-based ECG-interpretation programme for undergraduate medical students. BMC Med Educ (2008) 1.13
Long-range temporal correlations in alpha and beta oscillations: effect of arousal level and test-retest reliability. Clin Neurophysiol (2004) 1.12
Proinsulin is an independent predictor of coronary heart disease: Report from a 27-year follow-up study. Circulation (2002) 1.12
Reimbursement for continuous glucose monitoring: a European view. J Diabetes Sci Technol (2012) 1.11
Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study. Diabetes (2010) 1.11
C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant (2005) 1.10
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. Diab Vasc Dis Res (2014) 1.10
Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care (2003) 1.08
Molecular effects of proinsulin C-peptide. Biochem Biophys Res Commun (2002) 1.04
Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells. Am J Physiol Endocrinol Metab (2006) 1.04
Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition. Diabetes (2003) 1.02
Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes. Diabetes (2003) 1.02
AAPS-FDA Workshop White Paper: microdialysis principles, application, and regulatory perspectives. J Clin Pharmacol (2007) 1.01
Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women--a population-based study. Respir Med (2006) 1.00
The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy. Diabetes Technol Ther (2011) 1.00
C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients. Am J Physiol Endocrinol Metab (2003) 0.99
Serum adiponectin in elderly men does not correlate with fracture risk. J Clin Endocrinol Metab (2008) 0.99
Glucose recruits K(ATP) channels via non-insulin-containing dense-core granules. Cell Metab (2007) 0.99
Novel LC-MS/MS method for assay of 7alpha-hydroxy-4-cholesten-3-one in human plasma. Evidence for a significant extrahepatic metabolism. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.98
Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes. Diabetes Care (2004) 0.98
Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration. Clin Endocrinol (Oxf) (2006) 0.98
Attenuation of long-range temporal correlations in the amplitude dynamics of alpha and beta neuronal oscillations in patients with schizophrenia. Neuroimage (2012) 0.98
Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care (2004) 0.97
Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy. Diabetes Metab Res Rev (2002) 0.97
IGF-I/insulin hybrid receptors in human endothelial cells. Mol Cell Endocrinol (2005) 0.96
Adiponectin and risk of congestive heart failure. JAMA (2006) 0.96
Predictors of cognitive impairment in type 1 diabetes. Psychoneuroendocrinology (2007) 0.95
Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis. Arterioscler Thromb Vasc Biol (2002) 0.94
Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women. Am J Physiol Endocrinol Metab (2006) 0.94
Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample. Chest (2012) 0.94
Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease. Gastroenterology (2010) 0.93
Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation (2003) 0.93
Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes. J Clin Endocrinol Metab (2004) 0.92
Time course and variability of power in different frequency bands of EEG during resting conditions. Neurophysiol Clin (2004) 0.92
Loss of temporal lobe beta power in young adults with type 1 diabetes mellitus. Neuroreport (2002) 0.90
The interaction between impaired acute insulin response and insulin resistance predict type 2 diabetes and impairment of fasting glucose. Ups J Med Sci (2008) 0.90
Lowering apolipoprotein CIII delays onset of type 1 diabetes. Proc Natl Acad Sci U S A (2011) 0.90
Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation. Diabetes Care (2005) 0.89
Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. Growth Horm IGF Res (2008) 0.89
Efficacy of screening for high blood pressure in dental health care. BMC Public Health (2011) 0.89
Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes. Exp Diabetes Res (2008) 0.89
One-step purification of functional human and rat pancreatic alpha cells. Integr Biol (Camb) (2012) 0.89
Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation. Transpl Int (2011) 0.88
C-Peptide reverses nociceptive neuropathy in type 1 diabetes. Diabetes (2006) 0.88
Influence of C-peptide on early glomerular changes in diabetic mice. Diabetes Metab Res Rev (2006) 0.88
Loss of sensory discrimination after median nerve injury and activation in the primary somatosensory cortex on functional magnetic resonance imaging. J Neurosurg (2003) 0.87
Long-term hyperglycaemia impairs vascular smooth muscle cell function in women with type 1 diabetes mellitus. Diab Vasc Dis Res (2009) 0.86
C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant (2004) 0.86
Marked heterogeneity of human skeletal muscle lipolysis at rest. Diabetes (2002) 0.86
Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells. Growth Horm IGF Res (2006) 0.86
Clinical use of real-time continuous glucose monitoring. Curr Diabetes Rev (2008) 0.86
Low serum adiponectin concentrations are associated with insulin sensitivity independent of obesity in Sudanese subjects with type 2 diabetes mellitus. Diabetol Metab Syndr (2013) 0.85
Insulin resistance after cardiopulmonary bypass in the elderly patient. Scand Cardiovasc J (2007) 0.85
Comment on "Multiscale entropy analysis of complex physiologic time series". Phys Rev Lett (2004) 0.85